An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy-Reference-Cited by-同舟云学术

An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy

Published:2008-01 Issue:1 Volume:19 Page:92-98
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Van Cutsem E.,Siena S.,Humblet Y.,Canon J.-L.,Maurel J.,Bajetta E.,Neyns B.,Kotasek D.,Santoro A.,Scheithauer W.,Spadafora S.,Amado R.G.,Hogan N.,Peeters M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/1/92/433316/mdm399.pdf

Reference21 articles.

1. Facts about Cancer;World Health Organization,2007

2. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

3. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

5. Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases;McKay;Eur J Cancer,2002

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational research of new developments in targeted therapy of colorectal cancer;Pathology - Research and Practice;2023-12

2. Progress of research on molecular targeted therapies for colorectal cancer;Frontiers in Pharmacology;2023-08-08

3. Oral Mucositis;Orofacial Supportive Care in Cancer;2022

4. Transarterial Radioembolization in Patients With Unresectable Colorectal Cancer Liver Metastases;Journal of Clinical Oncology;2021-12-10

5. Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review;Journal of Immunotherapy and Precision Oncology;2021-02-01